Pathway for Diagnosing COPD
|
|
|
- Godwin Casey
- 10 years ago
- Views:
Transcription
1 Pathway for Diagnosing Visit 1 Registry Clients at Risk Patient presents with symptoms suggestive of Exertional breathlessness Chronic cough Regular sputum production Frequent bronchitis ; wheeze Occupational risk factors No clinical features of asthma Tool #1 is different from Asthma Patient presents opportunistically to Physician Smoker/Ex-Smoker (> 10 pack years) 40 years old No clinical features of asthma Tool #1 is different from Asthma Have you used tobacco in the last 30 days? Tool #2 Quit Now 3 Questions Never smoked May still have if symptomatic but consider alternate diagnosis OR Ex-smoker 1. Congratulate! 2. Record pack years & quit date Tool #3 Calculating pack years Tool #4 Chart marker 3. Tool #5 Lung Health Questionnaire NO Non YES PATIENT AT RISK OF Smoker 1. Assess readiness to quit: Tool #2 Quit Now 3 Questions 2. Record pack years Tool #3 Calculating pack years Tool #4 Chart marker 3. Tool #5 Lung Health Questionnaire Ready to quit 1. Tool #6 QuitNow Referral Form 2. Tool #7 Kick the Butt patient pamphlet 3. Tool #8 Penticton Integrated Health Centre (PIHC) Nicotine Intervention referral form #802603
2 Non Investigation of Possible OPTIONAL Visit 2 Screening Consider trial of short acting bronchodilator Tool #9 Respiratory Inhaler Quick Reference Guide Tool #10 Package of inhaler device teaching sheets Screen with 6 Tool #11 6 Quick Start Guide Normal Abnormal Refer for Pre & Post Spirometry Tool #12 PF Lab Referral Form # Consider 6 Annually Prn Smoker 1. Assess readiness to quit: Tool #2 Quit Now 3 Questions 2. Record pack years Tool #3 Calculating pack years Tool #4 Chart marker 3. Tool #5 Lung Health Questionnaire Not Ready To Quit Reassess next visit Offer help when ready Ready to quit 1. Tool #6 QuitNow Referral Form 2. Tool #7 Kick the Butt patient pamphlet 3. Tool #8 Penticton Integrated Health Centre (PIHC) Nicotine Intervention referral form #802603
3 Pathway for Diagnosing Visit 3 Confirmation Spirometry Results Normal result: Post Bronchodilator FEV1 > 80% FEV1/FVC > normal flow-volume loop Not Confirmed A normal result does not exclude the diagnosis of Asthma Tool #1 is different from Asthma Abnormal result: Post Bronchodilator FEV1/FVC < 0.7 Confirmed Exclude other potential diagnoses Arrange further investigations: Physical Examination, Detailed lung function, Chest X-Ray, Echocardiogram, Sputum, etc Follow Management Pathway Dr. Shannon Walker MD, FRCPC Patricia Rattee RRT, CRE Francis Hensen RN, BScN, M.Ed
4 Pathway for the Management of Suspected Investigation of Suspected Patient has confirmed Tool #13 Patient Care Flow Sheet Education Regarding Tool #14 Understanding Tool #15 Patient Education Resources MRC Level 3 Pulm Rehab: Tool #12 PF Lab Referral form If pt. unable to attend: Tool #18 Community Resp. Therapist Referral form Assessing Disability and Severity in Tool #16 Classification by Symptoms and Disability - MRC Dyspnea Scale Tool #17 Classification by Impairment of Lung Function MRC Level 2 Explore concerns Provide info re: Exercise, smoking and Self-management Canadian Thoracic Society Guidelines for Management Tool #19 CTS recommendations for management of Update -highlights for primary care
5 Canadian Thoracic Society Guidelines for Management Tool #19 CTS recommendations for management of Update -highlights for primary care Optimal Pharmacotherapy Tool #20 Optimal Pharmacotherapy Action Plan Tool #22 IH Flare-Up Action Plan Additional Interventions for Tool #21 Interventions for Annual Review by Physician Explore patients concerns Smoking cessation if appropriate Annual spirometry Review MRC scale & severity by spriometry Advise re: flu & pneumococcal vaccination Review patients pharmacological regime Check Inhaler Technique Review flare-up action plan Document exacerbation history Home oxygen assessment/abg if FEV1 < 50% or Oxygen saturation < 92% at rest on room air Assess for comorbidities Tool #23 Comorbidities Associated with Calculate BMI Annual Billing Code Tool # 42 Payment Description
6 Pathway for the Management of Acute Exacerbation of Patient has an acute exacerbation Increased dyspnea Increased cough and sputum Change in the colour of sputum for 24 hours or more Patient/family/caregiver starts Action Plan Contacts Physician for assessment appointment Tool #22 IH Exacerbation Flare-up Action Plan for antibiotics/prednisone use Factors to consider when determining whether to treat at home or in hospital: General condition Degree of breathlessness Ability to cope at home Level of consciousness Presence of cyanosis Worsening peripheral edema O2 saturation levels <92% on room air Go to ER or call 911 YES Concerning factors? NO Manage at home Patient admitted to in-patient care Condition deteriorates Monitoring by: Family Physician: Telephone F/U Tool #42 Payment Description Community Respiratory Therapist: Tool #18 Referral form # Discharge after treatment to: Family Physician Community Respiratory Therapist Respirologist prn Go to Stable Management Pathway Condition improves
7 Start at step appropriate to symptoms Tool 9 Respiratory Inhaler Quick Reference Guide Mild Optimal Pharmacotherapy Step 1 SABA - Salbutamol 100 mcg 2 puffs QID prn with spacer and/or SAAC - Ipratropium Bromide 20 mcg 2-4 puffs QID with spacer Step 2 Tool #20 Mild Persistent Dyspnea LAAC - Tiotropium Bromide 18 mcg od + SABA Salbutamol prn or LABA - Salmeterol 50 mcg 1 puff BID or Formoterol 6 or 12 mcg BID + SABA Salbutamol prn Step 3 Moderate-Severe Infrequent AE LAAC Tiotropium Bromide 18 mcg od + SABA Salbutamol prn < 1/year or LABA Salmeterol 50 mcg BID or Formoterol 12 mcg BID + Salbutamol prn If Persistent Dyspnea LAAC Tiotropium + LABA Salmeterol or Formoterol + SABA Salbutamol prn If Persistent Dyspnea LAAC Tiotropium + ICS/LABA Advair 250/50 mcg BID or Symbicort 200/6 mcg 2 puffs BID + SABA Salbutamol prn Moderate-Severe Step 4 LAAC Tiotropium bromide 18 mcg OD Frequent AE + 1/year ICS/LABA Advair 500/50 mcg BID or Symbicort 200/6 mcg 2 puffs BID + SABA Salbutamol 100 mcg 2 puffs QID prn If Persistent Dyspnea Consider adding oral Theophylline OR Consider adding PD4 Inhibitor Derived from the 2008 Update CTS Guideline for Step 5 If still symptomatic and/or in addition to pharmacotherapy at any time Options include one or more of the following: Referral for Pulmonary Rehabilitation Tool #12 PF lab Referral Form , if not already done Referral to Respirologist Tool #28 When to refer to a Respirologist - CTS Guidelines Referral for Home Oxygen Assessment Tool #12 PF Lab referral form Tool #34 Home Oxygen Program Subsidy Application Form Advanced Care Planning Tool #29 End of Life Care in CTS Guidelines Tool #30 GPAC Guidelines for Advanced Care Planning Tool #31 Comprehensive Approach to Management of Refractory Dyspnea in Advanced CTS Guidelines Tool #32 My Voice Patient Pamphlet Tool #33 Dr. Ann Gordon End of Life Video
8 REQUIRED Vaccinations Offer Annual Influenza Vaccine Offer Pneumococcal Vaccine Tool # 24 Vaccinations CTS Guidelines ADDITIONAL Annual Spirometry/Assess Oxygen Spirometry Tool #12 PF Lab Referral Form Home Oxygen Assessment if FEV1 < 50% Tool #12 PF Lab Referral Form Tool #34 Home Oxygen Program Subsidy Application Form Tool #21 Self Management/Education Education, collaborative goal setting, treatment plans Tool #25 Patient Self-Management Pamphlet Respirology Referral Tool #28 When to refer to a respirologist CTS Guidelines Exercise Advice If Patient MRC Scale Grade 2 Tool #26 Maintain an active lifestyle CTS Guidelines If Patient MRC Scale Grade 3 Pulmonary Rehabilitation Tool #12 PF Lab Referral Form Assessment of Disability & Severity Annual and prn assessment Tool #16 MRC dyspnea scale CTS guidelines Tool #17 Impairment of Lung Function CTS guidelines Interventions For Screen for Cardiovascular Risk Factors Primary and Secondary Prevention Calculate Body Mass Index (BMI) Tool #36 Body Mass Index Nomogram Screen For Osteoporosis Tool #35 Osteoporosis Risk Factors Action Plan Complete and Review Annually Tool #22 IH Flare-up Action Plan Identify & Manage Anxiety/Depression prn Tool #37 Patient Health Questionnaire (PHQ-9) Tool #38 Generalized Anxiety Disorder (GAD 7) Tool #39 Bounce Back Referral Form Tool #40 Bounce Back Patient Pamphlet Medications & Inhaler Technique Tool #9 Respiratory Inhaler Quick Reference Guide Tool #10 Package of Inhaler Device Teaching Sheets Screen for Obstructive Sleep Apnea (OSA) Tool #41 Epworth Sleepiness Scale Tool #12 'PF Lab Referral Form ' Smoking Cessation Tool #6 Quitnow.ca referral form Tool #7 Kick the Butt Patient Pamphlet Tool #8 PIHC Referral Form # Advance Care Planning Tool #29 End of Life Care in Tool #30 GPAC Guidelines for Advanced Care Planning Tool #31 Dyspnea Management Guidelines Tool #32 My Voice Tool #33 Dr. Ann Gordon s End of Life Video
Prevention of Acute COPD exacerbations
December 3, 2015 Prevention of Acute COPD exacerbations George Pyrgos MD 1 Disclosures No funding received for this presentation I have previously conducted clinical trials with Boehringer Ingelheim. Principal
COPD PROTOCOL CELLO. Leiden
COPD PROTOCOL CELLO Leiden May 2011 1 Introduction This protocol includes an explanation of the clinical picture, diagnosis, objectives and medication of COPD. The Cello way of working can be viewed on
COPD RESOURCE PACK SECTION 11. Fife Integrated COPD Care Pathways
COPD RESOURCE PCK SECTION 11 Fife Integrated COPD Care Pathways In this section: 1. COPD Guidance treatment at each stage of the disease 2. Overview of Respiratory (COPD) Integrated Pathway 3. Chronic
PLAN OF ACTION FOR. Physician Name Signature License Date
PLAN OF ACTION FOR Patient s copy (patient s name) I Feel Well Lignes I feel short directrices of breath: I cough up sputum daily. No Yes, colour: I cough regularly. No Yes I Feel Worse I have changes
COPD - Education for Patients and Carers Integrated Care Pathway
Patient NHS COPD - Education for Patients and Carers Integrated Care Pathway Date ICP completed:. Is the patient following another Integrated Care Pathway[s].. / If yes, record which other Integrated Care
RES/006/APR16/AR. Speaker : Dr. Pither Sandy Tulak SpP
RES/006/APR16/AR Speaker : Dr. Pither Sandy Tulak SpP Definition of Asthma (GINA 2015) Asthma is a common and potentially serious chronic disease that imposes a substantial burden on patients, their families
Hospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care
Hospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care Charley P. Starnes, RRT, RCP Clinical Respiratory Specialist- COPD Education Important Milestones July 2011-
COPD Prescribing Guidelines
South Staffordshire Area Prescribing Group COPD Prescribing Guidelines Inhaler choices in this guideline are different from previous versions produced by the APG. It is not expected patients controlled
Waterloo Wellington Rehabilitative Care System Integrated Care Pathway for COPD Stream of Care (short version)
Waterloo Wellington Rehabilitative Care System Integrated Care Pathway for COPD Stream of Care (short version) Care Setting ACUTE Activity Confirmation of COPD diagnoses: If time and the patient s condition
National Learning Objectives for COPD Educators
National Learning Objectives for COPD Educators National Learning Objectives for COPD Educators The COPD Educator will be able to achieve the following objectives. Performance objectives, denoted by the
Pulmonary Rehabilitation in Newark and Sherwood
Pulmonary Rehabilitation in Newark and Sherwood With exception of smoking cessation pulmonary rehabilitation is the single most effective intervention for any patient with COPD. A Cochrane review published
COPD MANAGEMENT PROTOCOL STANFORD COORDINATED CARE
I. PURPOSE To establish guidelines f the collabative management of patients with a diagnosis of chronic obstructive pulmonary disease (COPD) who are not adequately controlled and to define the roles and
IN-HOME QUALITY IMPROVEMENT. BEST PRACTICE: DISEASE MANAGEMENT Chronic Obstructive Pulmonary Disease NURSE TRACK
IN-HOME QUALITY IMPROVEMENT BEST PRACTICE: DISEASE MANAGEMENT Chronic Obstructive Pulmonary Disease NURSE TRACK Best Practice Intervention Packages were designed for use by any In-Home Provider Agency
Bronchodilators in COPD
TSANZSRS Gold Coast 2015 Can average outcomes in COPD clinical trials guide treatment strategies? Long live the FEV1? Christine McDonald Dept of Respiratory and Sleep Medicine Austin Health Institute for
Chronic obstructive pulmonary disease (COPD)
Chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) is the name for a group of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways
Chronic Obstructive Pulmonary Disease (COPD) Admission Order Set
Patient Name: PHN: Page 1/1 Admit to Dr: Notified Consult: Dr: Family Dr: Precautions: Contact Droplet Enhanced Droplet Airborne - Reason: _ Code Status: Full Resuscitation or Consults: Reason: Dietician
CLINICAL PATHWAY. Acute Medicine. Chronic Obstructive Pulmonary Disease
CLINICAL PATHWAY Acute Medicine Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Table of Contents (tap to jump to page) INTRODUCTION 1 Scope of this Pathway 1 Pathway Contacts
How To Test For A Lung Cancer
SPIROMETRY REFERRAL FORM COPD/ASTHMA/OTHER SCREENING APPT DATE: TIME: PATIENT NAME: DOB: PHN: PHONE: DIAGNOSIS: TRANSLATION SERVICE REQUIRED? / NO SPECIFY INFECTION PRECAUTIONS? /NO SPECIFY Date: Ordering
COPD. What is COPD? How many people have COPD in Canada? Who gets COPD?
What is COPD? COPD stands for Chronic Obstructive Pulmonary Disease. It is a long-term lung disease that makes it difficult for air to move into and out of the lungs. COPD is used to describe a few lung
Before prescribing for COPD management, the patient should have had appropriate assessment, including spirometry, as per NICE guidelines.
Formulary Guidance for Management of COPD patients Before prescribing for COPD management, the patient should have had appropriate assessment, including spirometry, as per NICE guidelines. For inhaler
Southwark Clinical Commissioning Group Lambeth Clinical Commissioning Group
Getting the Vision Right: A multi-disciplinary approach to providing integrated care for respiratory patients Dr Noel Baxter, GP NHS Southwark CCG Dr Irem Patel, Integrated Consultant Respiratory Physician
COPD and Asthma Differential Diagnosis
COPD and Asthma Differential Diagnosis Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in America. Learning Objectives Use tools to effectively diagnose chronic obstructive
AECOPD: Management and Prevention
AECOPD: Management and Prevention Neil MacIntyre MD Duke University Medical Center Durham NC AECOPD: Management and Prevention AECOPD: Definitions and impact Acute management of AECOPD Preventing AECOPD.
An Overview of Asthma - Diagnosis and Treatment
An Overview of Asthma - Diagnosis and Treatment Asthma is a common chronic disorder of the airways that is complex and characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness,
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT
Management of exacerbations in chronic obstructive pulmonary disease in Primary Care
Management of exacerbations in chronic obstructive pulmonary disease in Primary Care Acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with significant morbidity and mortality.
NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.
Objectives. Asthma Management
Objectives Asthma Management BREATHE Conference Allergy and Asthma Specialists PC Christine Malloy MD March 22, 2013 Review the role of inflammation in asthma Discuss the components of the EPR-3 management
Global Initiative for Chronic Obstructive Lung Disease
Global Initiative for Chronic Obstructive Lung Disease POCKET GUIDE TO COPD DIAGNOSIS, MANAGEMENT, AND PREVENTION A Guide for Health Care Professionals REVISED 2011 Global Initiative for Chronic Obstructive
understanding the professional guidelines
SEVERE ASTHMA understanding the professional guidelines This guide includes information on what the European Respiratory Society (ERS) and the American Thoracic Society (ATS) have said about severe asthma.
COPD. (Chronic Obstructive Pulmonary Disease) (Emphysema) (Chronic Bronchitis) Education For Our Community
COPD (Chronic Obstructive Pulmonary Disease) (Emphysema) (Chronic Bronchitis) Education For Our Community Chronic Obstructive Pulmonary Disease (COPD) Definition Chronic obstructive pulmonary disease (COPD)
Guidance to support the stepwise review of combination inhaled corticosteroid therapy for adults ( 18yrs) in asthma
Guidance to support the stepwise review of combination inhaled corticosteroid therapy for adults ( 18yrs) in asthma Important Complete asthma control needs to be achieved for at least 12 weeks before attempting
Pulmonary Rehabilitation: more than just an exercise prescription
Pulmonary Rehabilitation: more than just an exercise prescription Robert Stalbow, RRT, RCP Pulmonary Rehabilitation Therapist Oregon Heart & Vascular Institute Objectives To describe the role of pulmonary
Exploratory data: COPD and blood eosinophils. David Price: 9.23-9.35am
Exploratory data: COPD and blood eosinophils David Price: 9.23-9.35am Blood Eosinophilia in COPD The reliability and utility of blood eosinophils as a marker of disease burden, healthcare resource utilisation
Clinical Guideline. Recommendation 3: For stable COPD patients with respiratory symptoms
Clinical Guideline Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians,
Insights for Improvement: Advancing COPD Care Through Quality Measurement. An NCQA Insights for Improvement Publication
2009 Insights for Improvement: Advancing COPD Care Through Quality Measurement An NCQA Insights for Improvement Publication Chronic obstructive pulmonary disease (COPD) includes chronic bronchitis, emphysema,
Clinical Guideline. Recommendation 3: For stable COPD patients with respiratory symptoms
Clinical Guideline Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians,
Wandsworth Respiratory Clinical Reference Group Annual Progress Report 2014/15
Wandsworth Respiratory Clinical Reference Group Annual Progress Report 2014/15 April 2015 Dr Kieron Earney & Kate Symons Acknowledgements Dr Sarah Deedat Public Health Lead for Long Term Conditions 1 1.
The patient s response to therapy within the first hour in the Emergency Room is one of the most reliable ways to predict need for hospitalization.
Emergency Room Asthma Management Algorithm The Emergency Room Asthma Management Algorithm is to be used for any patient seen in the Emergency Room with the diagnosis of asthma. (The initial history should
These factors increase your chance of developing emphysema. Tell your doctor if you have any of these risk factors:
Emphysema Pronounced: em-fiss-see-mah by Debra Wood, RN En Español (Spanish Version) Definition Emphysema is a chronic obstructive disease of the lungs. The lungs contain millions of tiny air sacs called
April 2015 CALGARY ZONE CLINICAL REFERENCE PULMONARY CENTRAL ACCESS & TRIAGE
April 2015 CALGARY ZONE CLINICAL REFERENCE CENTRAL ACCESS & TRIAGE Introduction Pulmonary consulting services are organized through the Calgary Zone Pulmonary Central Access and Triage (PCAT). Working
Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)
Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) Geisinger Health System Case Study Organization Profile Geisinger Health System is a physician-led, fully integrated
Understanding COPD. An educational health series from
Understanding COPD An educational health series from Our Mission since 1899 is to heal, to discover, and to educate as a preeminent healthcare institution. We serve by providing the best integrated and
Smoking Cessation Program
Smoking Cessation Program UHN Information for people who are ready to quit smoking Read this information to learn: why you should quit smoking how the Smoking Cessation Program works treatments to help
To provide standardized Supervised Exercise Programs across the province.
TITLE ALBERTA HEALTHY LIVING PROGRAM SUPERVISED EXERCISE PROGRAM DOCUMENT # HCS-67-01 APPROVAL LEVEL Executive Director Primary Health Care SPONSOR Senior Consultant Central Zone, Primary Health Care CATEGORY
Community health care services Alternatives to acute admission & Facilitated discharge options. Directory
Community health care services Alternatives to acute admission & Facilitated discharge options Directory Introduction The purpose of this directory is to provide primary and secondary health and social
Sponsor Novartis Pharmaceuticals
Clinical Trial Results Database Page 1 Sponsor Novartis Pharmaceuticals Generic Drug Name Indacaterol Therapeutic Area of Trial Chronic Obstructive Pulmonary Disease (COPD) Indication studied: COPD Study
30 DAY COPD READMISSIONS AND PULMONARY REHAB
30 DAY COPD READMISSIONS AND PULMONARY REHAB Trina M. Limberg, Bs, RRT, FAARC, MAACVPR Director, Preventative Pulmonary and Rehabilitation Services UC San Diego Health System OVERVIEW The Impact of COPD
Chronic Obstructive Pulmonary Disease Patient Guidebook
Chronic Obstructive Pulmonary Disease Patient Guidebook The Respiratory System The respiratory system consists of the lungs and air passages. The lungs are the part of the body where gases are exchanged
Drug therapy SHORT-ACTING BETA AGONISTS SHORT-ACTING ANTICHOLINERGICS LONG-ACTING BETA AGONISTS LONG-ACTING ANTICHOLINERGICS
Drug therapy 6 6.1 What is the role of bronchodilators in COPD? 52 SHORT-ACTING BETA AGONISTS 6.2 How do short-acting beta agonists work? 52 6.3 What are the indications for their use? 52 6.4 What is the
Exploring the Chronic Obstructive Pulmonary Disease (COPD) Clinical Pathway. Health Quality Ontario s integrated episode of care for COPD
Exploring the Chronic Obstructive Pulmonary Disease (COPD) Clinical Pathway Health Quality Ontario s integrated episode of care for COPD Dr. Charlie Chan Health Quality Ontario Expert Panel Co-Chair May/June
Respiratory Care. A Life and Breath Career for You!
Respiratory Care A Life and Breath Career for You! Respiratory Care Makes a Difference At 9:32 am, Lori Moreno brought a newborn baby struggling to breathe back to life What have you accomplished today?
Pulmonary Rehabilitation. Steve Crogan RRT Pulmonary Rehabilitation, University of Washington Medical Center Seattle, Washington 10/13/07
Pulmonary Rehabilitation Steve Crogan RRT Pulmonary Rehabilitation, University of Washington Medical Seattle, Washington 10/13/07 Pulmonary Rehabilitation Created in the 1970 s Initially intended for COPD
2015 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older)
2015 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered
Breathe With Ease. Asthma Disease Management Program
Breathe With Ease Asthma Disease Management Program MOLINA Breathe With Ease Pediatric and Adult Asthma Disease Management Program Background According to the National Asthma Education and Prevention Program
Improvement in Dyspnea Implementing Pulmonary Rehabilitation in the Home
Improvement in Dyspnea Implementing Pulmonary Rehabilitation in the Home Mary Cesarz MS, PT Lisa Gorski MS, APRN, BC, FAAN Wheaton Franciscan Home Health & Hospice Milwaukee, WI Objectives To identify
Success and Survival in Pulmonary Rehab
Success and Survival in Pulmonary Rehab 35 Years and Still Growing Valerie McLeod, RRT Manager, Pulmonary Rehabilitation McLaren Flint, MI Disclosure Information I have no disclosures. While some brands
Lothian Guideline for Domiciliary Oxygen Therapy Service for COPD
Lothian Guideline for Domiciliary Oxygen Therapy Service for COPD This document describes the standard for clinical assessment, prescription, optimal management and follow-up of patients receiving domiciliary
Medication and Devices for Chronic Obstructive Pulmonary Disease (COPD)
Medication and Devices for Chronic Obstructive Pulmonary Disease (COPD) Patients with COPD take a wide variety of medicines to manage their symptoms these include: Inhaled Short Acting Bronchodilators
3/11/15. COPD Disease Management Tackling the Transition. Objectives. Describe the multidisciplinary approach to inpatient care for COPD patients
Faculty Disclosures COPD Disease Management Tackling the Transition Dr. Cappelluti has no actual or potential conflicts of interest associated with this presentation. Jane Reardon has no actual or potential
On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children
7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists
Irish Association for Emergency Medicine (IAEM) submission to the National COPD Strategy
31 st Irish Association for Emergency Medicine (IAEM) submission to the National COPD Strategy 1 Introduction Chronic obstructive pulmonary disease (COPD) is an important disease for patients, the health
HealthCare Partners of Nevada. Heart Failure
HealthCare Partners of Nevada Heart Failure Disease Management Program 2010 HF DISEASE MANAGEMENT PROGRAM The HealthCare Partners of Nevada (HCPNV) offers a Disease Management program for members with
Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis What is Idiopathic Pulmonary Fibrosis? Idiopathic pulmonary fibrosis (IPF) is a condition that causes persistent and progressive scarring of the tiny air sacs (alveoli) in
Rehabilitation and Lung Cancer Resection. Roberto Benzo MD MS Mindful Breathing Laboratory Division of Pulmonary & CCM Mayo Clinic
Rehabilitation and Lung Cancer Resection Roberto Benzo MD MS Mindful Breathing Laboratory Division of Pulmonary & CCM Mayo Clinic Disclosure Funded by the National Cancer Institute NIH for Preoperative
Topic: New Treatment = Better Outcome?
Session on COPD: Novel Concepts and Promising New Drugs Topic: New Treatment = Better Outcome? Through a CME Grant sponsored by New Treatment = Better Outcome? Tim S. Trinidad, MD Disclosure Present: COPD
How To Improve Health Care In South Essex
SEPT Clinical Health Psychology Service SOUTH ESSEX QIPP PROJECT Clinical Lead: Dr Greg Wood, Consultant Clinical Psychologist Clinical Health Psychology Initiatives Proposals posited locally: identified
FIBROGENIC DUST EXPOSURE
FIBROGENIC DUST EXPOSURE (ASBESTOS & SILICA) WORKER S MEDICAL SCREENING GUIDELINE Prepared By Dr. T. D. Redekop Chief Occupational Medical Officer Workplace Safety & Health Division Manitoba Labour & Immigration
Pulmonary Associates of Richmond
Pulmonary Associates of Richmond Name: Address One: City: Home Phone#: Work Phone#: Cell Phone#: State: Zip: Sex: Social Security Number: Referring Doctor: of Birth: Employer: Primary Care Doctor: Employment
Tests. Pulmonary Functions
Pulmonary Functions Tests Static lung functions volumes Dynamic lung functions volume and velocity Dynamic Tests Velocity dependent on Airway resistance Resistance of lung tissue to change in shape Dynamic
Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW
Clinical Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW NQF 0105 PQRS 9 NQF 0002 PQRS 66 Antidepressant Medication Management Appropriate Testing for Children with Pharyngitis (2-18 years)
Standard of Care: Pulmonary Physical Therapy Management of the patient with pulmonary disease
BRIGHAM & WOMEN S HOSPITAL Department of Rehabilitation Services Physical Therapy Standard of Care: Pulmonary Case Type / Diagnosis: This standard of care applies to any patient with obstructive or restrictive
Medicare Part A. Pulmonary Rehab Program Services Web-Based Training February 25, 2010 - Q & As
Pulmonary Rehab Program Services Web-Based Training February 25, 2010 - Q & As The following are the question and answers from the Pulmonary Rehabilitation Program Services web-based training which was
Medications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources
Medications for Managing COPD in Hospice Patients Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources Goal of medications in COPD Decrease symptoms and/or complications Reduce frequency
RT AS PROJECT MANAGER:
RT AS PROJECT MANAGER: IMPROVING CARE TRANSITIONS DECREASES UNPLANNED READMISSIONS TAMMY JARNAGIN, BHS, RRT DIRECTOR CARDIOPULMONARY SERVICES, NEURODIAGNOSTICS, HOME MEDICAL EQUIPMENT Objectives Recognize
The new Heart Failure pathway
The new Heart Failure pathway An integrated and seamless Strategy Dr Sunil Balani Definition of Heart Failure The inability of the heart to pump blood at a rate commensurate with the requirements of metabolising
Respiratory Concerns in Children with Down Syndrome
Respiratory Concerns in Children with Down Syndrome Paul E. Moore, M.D. Associate Professor of Pediatrics and Pharmacology Director, Pediatric Allergy, Immunology, and Pulmonary Medicine Vanderbilt University
Medicines Use Review Supporting Information for Asthma Patients
Medicines Use Review Supporting Information for Asthma Patients What is asthma? Asthma is a chronic inflammatory disorder of the airways. The inflammation causes an associated increase in airway hyper-responsiveness,
Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD)
Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Development of disability in COPD The decline in airway function may initially go unnoticed as people adapt their lives to avoid
Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)
Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD) DuPage Medical Group Case Study Organization Profile Established in 1999, DuPage Medical Group (DMG) is a multispecialty